Myelodysplastic Syndromes
What's New
Last Posted: Jun 29, 2023
- Telomere Length and Clonal Hematopoiesis.
George Vassiliou et al. N Engl J Med 2023 5 (26) 2481-2484 - A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
Qiujin Shen et al. Cancer research communications 2023 2(4) 258-276 - Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.
Tatsuya Konishi et al. Scientific reports 2023 13(1) 2641 - MDS-287 Genetic Landscape of Somatic Myeloid Mutations in the Presence of Rare TERT Variants and Their Relation to Myeloid Neoplasia.
Ferrer Alejandro et al. Clinical lymphoma, myeloma & leukemia 2022 22 Suppl 2S309 - A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
Wang Meifang et al. Frontiers in oncology 2022 12844978 - TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Yabe Mariko et al. Cancers 2021 13(21) - A Geno-Clinical Decision Model for the Diagnosis of Myelodysplastic Syndromes.
Radakovich Nathan et al. Blood advances 2021 - Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
Nazha Aziz et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 JCO2002810 - Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
Duncavage Eric J et al. The New England journal of medicine 2021 384(10) 924-935 - GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.
Bruzzese Antonella et al. Cancers 2020 Oct 12(10) - Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies.
Dou Aixia et al. Journal of cellular immunology 2020 2(5) 237-244 - Behçet disease (BD) and BD-like clinical phenotypes: NF-kB pathway in mucosal ulcerating diseases.
Perazzio Sandro F et al. Scandinavian journal of immunology 2020 Sep e12973 - The Evolving Landscape of Myelodysplastic Syndrome Prognostication.
Shreve Jacob et al. Clinical hematology international 2020 Jun 2(2) 43-48 - Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Schratz Kristen E et al. Hematology/oncology clinics of North America 2020 Apr 34(2) 333-356 - Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
Pine Alexander B et al. Leukemia & lymphoma 2020 Feb 1-10 - Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
Duetz Carolien et al. Current opinion in oncology 2019 Dec - Genetic predisposition to MDS: diagnosis and management.
Furutani Elissa et al. Hematology. American Society of Hematology. Education Program 2019 Dec 2019(1) 110-119 - Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence.
Nazha Aziz et al. JCO precision oncology 2019 3 - Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
Migdady Yazan et al. Clinical lymphoma, myeloma & leukemia 2018 18(8) 528-532 - Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
Bräuninger Andreas et al. The Journal of molecular diagnostics : JMD 2018 20(3) 344-354
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: